LISAvienna: BIO-Europe Spring in Vienna and a special edition of our Highlights newsletter

On this occasion of BIO-Europe Spring, we are publishing a special edition of our bi-annual English-language “Highlights”-newsletter.

Here is what we can expect to find:

  • Insights on Vienna’s characteristics as a prime business location for biotech, pharma and medtech companies provided by:
    • Andreas Goppelt (Ottobock CTO and Managing Director at the Vienna subsidiary Ottobock Healthcare Products GmbH)
    • Peter Llewellyn-Davies (CEO APEIRON Biologics AG)
    • Eva Prieschl-Grassauer (CSO Marinomed Biotech AG)
    • Barbara Rangetiner (General Manager at Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.)
    • Harald Schnidar (CEO SCARLETRED Holding GmbH)
    • Erich Tauber (CEO Themis Bioscience GmbH)
    • Philipp von Lattorff (Managing Director at Boehringer Ingelheim RCV GmbH & Co KG)
  • Facts and figures on the life sciences sector in Austria and Vienna
  • Global players manufacturing drugs and medical devices in Austria
  • A list of dedicated biotech companies in Vienna
  • Recent news, including Marinomed’s IPO
  • Information on LISAvienna’s free services

Enjoy reading!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)